Navigation Links
DNA2.0 Introduces Powerful, Free Gene Design Software
Date:6/17/2010

Gene Designer 2.0 Brings Creative Ideas to Life With Stunning Graphics and a Complete Set of Intuitive Gene-Building Tools

(PRWEB) June 17, 2010 -- DNA2.0, the leading gene synthesis and protein engineering company, today announced the availability of an innovative software tool for designing DNA sequences: Gene Designer 2.0. Building on the success of the original Gene Designer, version 2.0 delivers a sophisticated graphic interface and drag-and-drop functionality for creating genes, whether making alterations to naturally occurring sequences or designing novel ones. Gene Designer 2.0 is completely free: DNA2.0 has devoted significant expertise to this one-of-a-kind software tool so that a wide range of biologists can experience the flexibility of designing and producing genes through DNA synthesis.

“Gene Designer 2.0 enables you to put your imagination to work and guides you through every step, from inspiration to synthesized gene,” said Claes Gustafsson, Ph.D., Co-Founder and Vice President at DNA2.0. “With version 2.0 we’ve provided a more dynamic interface and powerful new tools to make bringing your creative ideas to life easier than ever before.”

Gene Designer 2.0 is built to design novel sequences—rather than analyze existing sequences—making it an ideal software tool for synthetic biology. Without a comprehensive design tool, molecular biologists can be hampered by unanticipated permutations of their design or by the sheer volume of data involved in even the simplest genes. Furthermore, imagining a novel sequence requires the ability to try out different combinations and make adjustments with ease. Gene Designer 2.0 is fundamentally different from all other sequence manipulation tools and was created to enable scientists to design sequences de novo without being limited by what nature can provide.

“Gene Designer 2.0 puts the future of synthetic biology into your hands today,” said Jean Peccoud, Ph.D., Principal Investigator of the Virginia Bioinformatics Institute at Virginia Tech, the group responsible for the development of GenoCAD. “As biology evolves to an engineering discipline, it is essential that we have effective design tools that allow scientists to advance biology through the power of computing. Gene Designer 2.0 is the most dynamic, graphically-rich and user-friendly of a new class of tools for gene design de novo.”

Features & Improvements for v2.0

Gene Designer 2.0 comes loaded with new features, including a simplified user experience and a powerful, intuitive drag-and-drop interface for moving sequence elements within or between constructs. Gene Designer enables you to capture you entire gene design process in one efficient application, using a range of design tools purposely built for the task, including:

*Intelligent, fast and easy-to-use algorithms for in-silico cloning, codon optimization, back translation and primer design
*Graphically-rich molecular view to display, annotate and edit your construct
*Customizable database to quickly store, manage and track genetic elements, genes and constructs   
*Cloning Tool which can cut, combine and clone any vector and insert with drag-and-drop convenience

Gene Designer 2.0 also allows you to effortlessly remove or add restriction sites or other sequence motifs, recode open-reading frames, check translation frames and fusion junctions and instantly design oligonucleotides for sequencing primers with a real-time melting point calculator. Finally, users can directly order newly-designed synthetic DNA fragments from DNA2.0 via Gene Designer.

Gene Designer 2.0 is currently in beta.

IP Protection and Superior Customer Service

Whether designing genes with Gene Designer 2.0 or utilizing DNA2.0’s patented gene optimization technology, DNA2.0 offers the most integrated and efficient path from virtual sequence to expressed protein. While many other gene synthesis companies offshore manufacturing to areas of the world with lax IP protection, all DNA2.0 genes are made at the company’s state-of-the-art facility in Menlo Park, thus ensuring the greatest security for patented or confidential sequences. DNA2.0 guarantees researchers high-quality synthetic genes, delivered on time, every time.

About DNA2.0
Founded in 2003, DNA2.0 is the leading synthetic genomics company. It is the fastest provider of synthetic genes, based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene synthesis process and new protein optimization technologies. The tools and applications brought to market by DNA2.0 are transforming biology into an engineering discipline. The company is privately held and is headquartered in Menlo Park, Calif. For more information, please visit www.DNA20.com.

# # #

Read the full story at http://www.prweb.com/releases/2010/06/prweb4155284.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
2. DNA2.0 Launches New Website: Enhanced Design and Free Bioinformatics Tools Demonstrate DNA2.0's Customer Focus
3. RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research
4. DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors
5. DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
6. DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein Expression
7. DNA2.0 and Blue Sky Biotech Announce Strategic Alliance for Bundled Customer Experience From Gene Synthesis to Purified Protein
8. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
9. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
10. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
11. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DNA2.0 Introduces Powerful, Free Gene Design Software 
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, which creates ... has submitted a 510(k) to the FDA, requesting clearance of the MyoCycle Home ... stimulation (FES) technology. , The submission marks a major milestone for the ...
(Date:1/18/2017)... ... , ... Thirty-six startup companies in University City and Center City have been ... Economic Development in 2016 as part of the Keystone Innovation Zone (KIZ) Tax Credit ... and represent the highest number of awards to the largest number of companies in ...
(Date:1/18/2017)... Research Future published a half-cooked research report on Global Cancer Diagnostics ... CAGR of 12% during the period 2016 to 2022. ... ... without any control. These abnormal cells have the ability to invade ... spread to other parts of the body through the blood and ...
(Date:1/17/2017)... Jan. 17, 2017 Roka Bioscience, Inc. (NASDAQ: ... solutions for the detection of foodborne pathogens today announced the appointment ... succeeds Paul Thomas , the Company,s President and CEO since ... Board of Directors.  The changes are effective today. In ... today. ...
Breaking Biology Technology:
(Date:12/16/2016)... 2016   IdentyTechSolutions America LLC , a ... solutions and a cutting-edge manufacturer of software and ... offering seamless, integrated solutions that comprise IDT biometric ... solutions provide IdentyTech,s customers with combined physical identification ... crime and theft. "We are proud ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
Breaking Biology News(10 mins):